Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart

dc.contributor.authorMienert, Tino
dc.contributor.authorEsmaeili, Anoosh
dc.contributor.authorSteinbrenner, Blanka
dc.contributor.authorKhalil, Markus
dc.contributor.authorMüller, Matthias
dc.contributor.authorAkintuerk, Hakan
dc.contributor.authorKerst, Gunter
dc.contributor.authorSchranz, Dietmar
dc.date.accessioned2022-11-11T15:32:30Z
dc.date.available2022-11-11T15:32:30Z
dc.date.issued2021
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/8304
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-7693
dc.language.isoen
dc.rightsNamensnennung - Nicht kommerziell 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddcddc:610
dc.titleCardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.epage202
local.source.journaltitlePediatric drugs
local.source.spage195
local.source.urihttps://doi.org/10.1007/s40272-021-00438-2
local.source.volume23

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1007_s40272-021-00438-2.pdf
Größe:
787.84 KB
Format:
Adobe Portable Document Format